GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Net Margin %

Mangalam Drugs & Organics (BOM:532637) Net Margin % : 0.51% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Mangalam Drugs & Organics's Net Income for the three months ended in Dec. 2023 was ₹5 Mil. Mangalam Drugs & Organics's Revenue for the three months ended in Dec. 2023 was ₹970 Mil. Therefore, Mangalam Drugs & Organics's net margin for the quarter that ended in Dec. 2023 was 0.51%.

The historical rank and industry rank for Mangalam Drugs & Organics's Net Margin % or its related term are showing as below:

BOM:532637' s Net Margin % Range Over the Past 10 Years
Min: -3.59   Med: 4.39   Max: 7.36
Current: -2.47


BOM:532637's Net Margin % is ranked worse than
62.51% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.19 vs BOM:532637: -2.47

Mangalam Drugs & Organics Net Margin % Historical Data

The historical data trend for Mangalam Drugs & Organics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Net Margin % Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.92 7.36 4.39 - -2.47

Mangalam Drugs & Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -10.96 -4.38 0.51 3.46

Competitive Comparison of Mangalam Drugs & Organics's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Net Margin % falls into.



Mangalam Drugs & Organics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Mangalam Drugs & Organics's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-90.717/3673.536
=-2.47 %

Mangalam Drugs & Organics's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=4.979/970.459
=0.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangalam Drugs & Organics  (BOM:532637) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Mangalam Drugs & Organics Net Margin % Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics (BOM:532637) Business Description

Traded in Other Exchanges
Address
239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines